ArticleAnnals of internal medicine2023
In moderately to severely active UC, etrasimod increased remission at 12 and 52 wk but increased adverse events.
Reem Al-Jabri et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
ArticleAnnals of internal medicine2023
Reem Al-Jabri et al.PubMed ↗Publisher ↗
No numbers read from the abstract.